Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21250117 | 0.88 | GPR3 (0.35) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL18475758 | 0.87 | GPR3 (0.40) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL18560415 | 0.83 | GPR3 (0.40) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL22600637 | 0.76 | GPR3 (0.43) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL17950785 | 0.76 | GPR3 (0.39) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL14185908 | 0.73 | CYP1A2 (0.33) | — | |
| SCHEMBL21704016 | 0.72 | GPR3 (0.35) | GPR3ALDH1A1LMNAKDM4ECASP1 | |
| SCHEMBL16325408 | 0.72 | ALDH1A1 (0.38) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL29700327 | 0.71 | GPR3 (0.67) | GPR3MAPTRAB9AMEN1KMT2A | |
| SCHEMBL430470 | 0.71 | GPR3 (0.67) | GPR3MAPTRAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10825995-B2 | Material for photoelectric conversion element for an imaging element, and photoelectric conversion element including same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2020-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10825995-B2 | Material for photoelectric conversion element for an imaging element, and photoelectric conversion element including same | SLC19A1, SLC19A2, CRY1 | GPR3 4367/4885MAPT 446/4885RAB9A 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.